Triple
T6065081
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | SMN2 |
E135135
|
entity |
| Predicate | therapeuticTargetIn |
P20980
|
FINISHED |
| Object | spinal muscular atrophy type 1 |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: spinal muscular atrophy type 1 | Statement: [SMN2, therapeuticTargetIn, spinal muscular atrophy type 1]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: therapeuticTargetIn Context triple: [SMN2, therapeuticTargetIn, spinal muscular atrophy type 1]
-
A.
hasMolecularTarget
Indicates that one entity (such as a drug or compound) is directed toward, binds to, or specifically interacts with a particular molecular target (such as a protein, receptor, or gene).
-
B.
hasTargetDisease
chosen
Indicates that an entity (such as a treatment, study, or intervention) is directed toward, intended to affect, or primarily concerned with a specified disease.
-
C.
regulatoryTarget
Indicates that one entity is subject to control, influence, or governance by another entity under a regulatory or rule-based framework.
-
D.
hasTherapeuticGoal
Indicates that an action, treatment, or intervention is undertaken with the intention of achieving a specific therapeutic or health-related outcome.
-
E.
potentialTherapeuticUse
Indicates that something is being considered or investigated as a possible treatment or therapy for a condition or disease.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c00878d06881909ee78e88913bf890 |
completed | March 22, 2026, 3:19 p.m. |
| NER | Named-entity recognition | batch_69c05723c91c819090b4d4672e72f9f3 |
completed | March 22, 2026, 8:54 p.m. |
| PD | Predicate disambiguation | batch_69c049f031408190b08b2766237c5dd0 |
completed | March 22, 2026, 7:58 p.m. |
Created at: March 22, 2026, 4:10 p.m.